Free Trial

Pharma Names With Outlook Pos Or Neg Ahead Of Earnings Season

CREDIT UPDATE

Ticker

Name

Earnings

Moody's

S&P

Fitch

Chg 1yr

Chg 3m

LLY US

Eli Lilly & Co

08/08/2024

POS

94.6

16.9

NOVOB DC

Novo Nordisk A/S

07/08/2024

POS

80.5

13.3

AMGN US

Amgen Inc

06/08/2024

NEG

NEG

37.5

15.4

DHR US

Danaher Corp

23/07/2024

POS

14.3

-0.8

SYK US

Stryker Corp

30/07/2024

POS

11.4

-4.4

MRK US

Merck & Co Inc

30/07/2024

POS

10.1

-1.4

VTRS US

Viatris Inc

08/08/2024

NEG

5.0

-11.7

TMO US

Thermo Fisher Scientific Inc

24/07/2024

POS

3.2

-6.1

SAN FP

Sanofi SA

25/07/2024

POS

-7.0

2.5

JNJ US

Johnson & Johnson

17/07/2024

NEG

-10.8

-4.5

RVTY US

Revvity Inc

01/08/2024

NEG

-12.9

0.9

FME GR

Fresenius Medical Care AG

30/07/2024

NEG

-17.7

3.5

BAX US

Baxter International Inc

26/07/2024

NEG

-25.8

-22.2

BMY US

Bristol-Myers Squibb Co

26/07/2024

NEG

-37.8

-22.1

BAYN GR

Bayer AG

06/08/2024

NEG

-48.4

-7.6

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.